If there is one thing all cancers have in common, it is, they have nothing in common.
The transcriptome gives a fuller picture of how genes are expressed. RNA sequencing allows for more detailed information on cellular pathways and expression levels in cancer studies.
Researchers at the Broad Institute of MIT and Harvard have reported that their platform, SHERLOCK, now can be used to detect viruses directly in clinical samples such as blood or saliva.
Cancer has always been thought of as something that grows rapidly and uncontrollably, but this view may be wrong. New evidence suggests that cancer has a smarter strategy than that.
Scientists have published the first detailed picture of the molecular structure of human telomerase, which will allow more targeted drug screens and intelligent design of new drugs.
Researchers have shown that not only the ‘where’ and the ‘when’ of long non-coding RNA expression is important for their function, but also the ‘how’.
Researchers have determined how satellite DNA, considered to be “junk DNA”, plays a crucial role in holding the genome together.
Material left out of common processes for sequencing genetic material in cancer tumours may actually carry important information about why only some people respond to immunotherapy.
Scientists have created a new tool that targets not DNA, but RNA, and used it to correct a protein imbalance in cells from a dementia patient, restoring them to healthy levels.
For previously healthy children, brain infections are rare. But about one out of every 10,000 people who are exposed to common viruses like herpes simplex or influenza will develop a potentially deadly disease, encephalitis.